Title of article :
T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita
Author/Authors :
Müller، نويسنده , , Ralf and Dahler، نويسنده , , Christiane and Mِbs، نويسنده , , Christian and Wenzel، نويسنده , , Elke and Eming، نويسنده , , Rüdiger and Messer، نويسنده , , Gerald and Niedermeier، نويسنده , , Andrea and Hertl، نويسنده , , Michael، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2010
Abstract :
Epidermolysis bullosa acquisita (EBA) is a severe immunobullous disease and is caused by IgG against type VII collagen (Col VII) of anchoring fibrils. In this study, utilizing ELISA and immunoblot, 13/15 EBA sera but 0/20 bullous pemphigoid sera and 0/30 healthy control sera showed IgG reactivity with distinct recombinant subregions of the non-collagenous domain 1 (NC1) of Col VII. In two EBA patients, IgG titers against Col VII-NC1 were grossly correlated to clinical disease activity. Moreover, Col VII-reactive T cells were identified in a representative EBA patient which recognized identical subdomains of Col VII-NC1. These findings strongly suggest that (1) the Col VII-NC1 ELISA is a powerful tool for making the diagnosis of EBA, (2) Col VII-specific IgG grossly relates to disease activity and (3) IgG reactivity is associated with T cell recognition of identical subdomains of Col VII-NC1.
Keywords :
epitope , T cell , Autoantibody , immunoadsorption , Rituximab , ELISA , ELISPOT , Collagen VII , Immunoblot , epidermolysis bullosa
Journal title :
Clinical Immunology
Journal title :
Clinical Immunology